the management of polycythemia vera with cytoreductive drug therapy
Published 1 year ago • 342 plays • Length 4:10Download video MP4
Download video MP3
Similar videos
-
10:20
new guidelines for the treatment and management of polycythemia vera
-
3:07
the current treatment algorithm for polycythemia vera
-
1:52
cytoreductive therapy for patients with pv
-
1:26
agents of interest being explored in essential thrombocythemia and polycythemia vera
-
2:46
an update on emerging therapies for the treatment of polycythemia vera
-
3:23
the role of rusfertide in polycythemia vera
-
1:30:12
conversation with an mpn specialist: focusing on essential thrombocythemia
-
21:07
chemotech clinical update - july 2024
-
10:56
identifying and communicating your polycythemia vera (pv) symptoms
-
1:39
upcoming agents in et and pv
-
4:48
an insight into the management of cytopenias in mf
-
1:56
5-year follow up results of long-term use of ropeginterferon alfa-2b in polycythemia vera
-
1:30
the verify trial: rusfertide in patients with polycythemia vera
-
1:30
the patient perspective of polycythemia vera and second-line treatment options
-
1:54
ongoing trials in polycythemia vera: low-pv & verify
-
2:14
risk-adapted treatment of et & pv
-
1:35
pv-pinpoint: a study investigating the diagnosis and management of polycythemia vera in the uk
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
5:21
challenges in the treatment and management of et and the need to improve therapeutic approaches
-
6:31
the current treatment landscape for polycythemia vera
-
2:08
phase iii trial of rusfertide in patients with polycythemia vera
-
3:06
the unmet needs of essential thrombocythemia and polycythemia vera patients